SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001019687-04-001537
Filing Date
2004-07-14
Accepted
2004-07-14 15:51:37
Documents
7
Period of Report
2004-04-30

Document Format Files

Seq Description Document Type Size
1 peregrine_10k-043004.htm 10-K 992769
2 peregrine_10kex10-93.txt EX-10.93 39625
3 peregrine_10kex-21.txt EX-21 541
4 peregrine_10kex23-1.txt EX-23.1 884
5 peregrine_10kex31-1.txt EX-31.1 3067
6 peregrine_10kex31-2.txt EX-31.2 3054
7 peregrine_10kex-32.txt EX-32 1497
  Complete submission text file 0001019687-04-001537.txt   1043687
Mailing Address 14282 FRANKLIN AVE TUSTIN CA 92780
Business Address 14282 FRANKLIN AVE TUSTIN CA 92780 7145086000
PEREGRINE PHARMACEUTICALS INC (Filer) CIK: 0000704562 (see all company filings)

IRS No.: 953698422 | State of Incorp.: DE | Fiscal Year End: 0430
Type: 10-K | Act: 34 | File No.: 000-17085 | Film No.: 04913874
SIC: 2835 In Vitro & In Vivo Diagnostic Substances